Cargando…
N-Acetylcysteine inhibits platelet–monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial
AIMS/HYPOTHESIS: The aim of this study was to determine whether oral dosing with N-acetylcysteine (NAC) increases intraplatelet levels of the antioxidant, glutathione (GSH), and reduces platelet–monocyte conjugation in blood from patients with type 2 diabetes. METHODS: In this placebo-controlled ran...
Autores principales: | Treweeke, A. T., Winterburn, T. J., Mackenzie, I., Barrett, F., Barr, C., Rushworth, G. F., Dransfield, I., MacRury, S. M., Megson, I. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464379/ https://www.ncbi.nlm.nih.gov/pubmed/22935960 http://dx.doi.org/10.1007/s00125-012-2685-z |
Ejemplares similares
-
Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes
por: Gibson, Kyle R, et al.
Publicado: (2011) -
Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis
por: Treweeke, A., et al.
Publicado: (2017) -
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
por: Roberts, Jacob, et al.
Publicado: (2021) -
Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus
por: Gawryś, Jakub, et al.
Publicado: (2020) -
Platelet hyperaggregability in high-fat fed rats: A role for intraplatelet reactive-oxygen species production
por: Monteiro, Priscila F, et al.
Publicado: (2012)